Menovazin

INSTRUCTION FOR MEDICAL USE OF THE MEDICINAL PRODUCT MENOVASIN

Composition:

Active substances: 100 ml of solution contains benzocaine 1 g, procaine hydrochloride 1 g, racemic menthol 2.5 g.

Excipient: ethanol 70%.

Pharmaceutical form. Topical alcoholic solution.

Main physicochemical properties: clear colorless liquid with a menthol odor.

Pharmacotherapeutic group. Products used locally for joint and muscular pain.

ATC code M02AX.

Pharmacological properties.

Pharmacodynamics. The drug has anti-pruritic action and local anesthetic effect. When applied to the skin and mucous membranes, it causes irritation of nerve endings, accompanied by a sensation of cold, mild burning, and tingling.

Exerts mild analgesic action.

Pharmacokinetics.

When applied locally, the drug does not enter the bloodstream.

Clinical characteristics.

Indications.

The drug is indicated for neuralgias, myalgias, and arthralgias.

Contraindications.

The drug is contraindicated in cases of hypersensitivity to procaine and other components of the drug.

Special precautions.

Do not apply to damaged skin or skin exhibiting allergic reactions. Do not apply to facial skin.

Do not violate the application instructions for the medicinal product, as this may harm health.

Interaction with other medicinal products and other types of interactions.

Components of the drug (procaine, anestezin) weaken the antibacterial effect of sulfonamide drugs. They enhance the effects of drugs with local anesthetic action.

When using any other medicinal products simultaneously, inform your doctor.

Special precautions for use.

Use during pregnancy or breastfeeding.

During pregnancy and breastfeeding, the use of this medicinal product is possible only if the expected benefit to the mother outweighs the potential risk to the fetus or infant.

Ability to affect reaction speed when driving or operating machinery.

No effect.

Method of administration and dosage.

The medication is for topical use. Painful skin areas should be rubbed with Minovazin 2–3 times a day. The duration of treatment depends on the form and severity of the disease, the drug's effectiveness, and the type of therapy (monotherapy or in combination with other medicinal agents).

Children.

Not recommended for children under 12 years of age.

Overdose.

With prolonged use, dizziness, general weakness, decreased arterial pressure, and allergic reactions may occur. If such symptoms appear, discontinue the medication, wash off any residue from the skin surface with water, and administer symptomatic therapy.

Side effects.

Allergic reactions are possible (hyperemia, skin irritation, itching, rash, swelling, urticaria).

If any adverse events occur, consult a physician!

Shelf life. 2 years.

Do not use the medication after the expiry date stated on the packaging.

Storage conditions.

Store in a place protected from light at a temperature not exceeding 25 °C.

Keep out of reach of children.

Packaging.

40 ml in bottles or in bottles with mechanical sprayers, in a carton or without a carton.

Supply category. Over-the-counter.

Manufacturer.

LLC "Mikrofarm".

Manufacturer's location and address of its business activity.

LLC "Mikrofarm".

20 Shevchenka St., Kharkiv, Ukraine, 61013.

Manufacturer/Applicant.

LLC "Ternofarm".

Manufacturer's location and address of its business activity / Applicant's location.

LLC "Ternofarm".

4 Fabrychna St., Ternopil, Ukraine, 46010.